We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.59%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$14B
AUM Growth
+$1.63B
(+13%)
Cap. Flow
+$225M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
16.45%
Holding
1,448
New
199
Increased
366
Reduced
275
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$154M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$89.6M |
| 3 |
Lockheed Martin
LMT
|
+$86.9M |
| 4 |
BCM
iPath Pure Beta Broad Commodity ETN
BCM
|
+$76.4M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$98.9M |
| 2 |
GE Aerospace
GE
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$67.4M |
| 5 |
Tapestry
TPR
|
+$60.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.01% |
| 2 | Technology | 14.16% |
| 3 | Financials | 12.66% |
| 4 | Industrials | 9.8% |
| 5 | Energy | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Medtronic
MDT
$107B
| $2.2M | 0.02% |
38,276
+18,640
| +95% | +$1.06M |
|
302
SLM Corp
SLM
$4.57B
| $2.2M | 0.02% |
233,773
| – | – |
|
|
PLL
303
DELISTED
PALL CORP
PLL
| $2.2M | 0.02% |
25,736
-857
| -3% | -$69.6K |
|
|
LNKD
304
DELISTED
LinkedIn Corporation
LNKD
| $2.2M | 0.02% |
10,125
-2,045
| -17% | -$466K |
|
|
VVC
305
DELISTED
Vectren Corporation
VVC
| $2.18M | 0.02% |
61,333
+5,180
| +9% | +$179K |
|
|
SGI
306
Somnigroup International
SGI
$15.1B
| $2.17M | 0.02% |
160,844
+100,004
| +164% | +$1.15M |
|
307
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
| $2.17M | 0.02% |
23,366
-4,136
| -15% | -$384K |
|
|
XL
308
DELISTED
XL Group Ltd.
XL
| $2.16M | 0.02% |
67,775
-450
| -0.7% | -$14K |
|
309
Churchill Downs
CHDN
$6.03B
| $2.15M | 0.02% |
144,180
+1,380
| +1% | +$20K |
|
|
MDC
310
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.15M | 0.02% |
92,441
| – | – |
|
311
Fidelity National Information Services
FIS
$21.5B
| $2.13M | 0.02% |
39,707
| – | – |
|
312
Benchmark Electronics
BHE
$2.91B
| $2.13M | 0.02% |
92,260
+9,160
| +11% | +$208K |
|
313
Lindsay Corp
LNN
$1.16B
| $2.1M | 0.02% |
25,380
| – | – |
|
314
Mondelez International
MDLZ
$77.7B
| $2.08M | 0.01% |
59,063
+19,837
| +51% | +$659K |
|
|
FBRC
315
DELISTED
FBR & Co. Common Stock
FBRC
| $2.05M | 0.01% |
77,670
+59,072
| +318% | +$1.59M |
|
316
Markel Group
MKL
$25B
| $2.03M | 0.01% |
3,496
-131
| -4% | -$71.1K |
|
317
AAR Corp
AIR
$5.15B
| $2M | 0.01% |
71,370
| – | – |
|
|
MODV
318
DELISTED
ModivCare
MODV
| $1.98M | 0.01% |
76,990
+49,760
| +183% | +$1.38M |
|
319
Stryker
SYK
$127B
| $1.97M | 0.01% |
26,196
+1,340
| +5% | +$97.8K |
|
|
RDS.A
320
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $1.9M | 0.01% |
26,637
-261,444
| -91% | -$17.6M |
|
321
Southwest Airlines
LUV
$22.1B
| $1.89M | 0.01% |
100,576
+96,745
| +2,525% | +$1.69M |
|
|
MHFI
322
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $1.87M | 0.01% |
23,854
+6,379
| +37% | +$458K |
|
323
BP
BP
$113B
| $1.86M | 0.01% |
46,795
+6,919
| +17% | +$258K |
|
324
Brookfield
BN
$102B
| $1.86M | 0.01% |
204,334
-7,205
| -3% | -$65.6K |
|
|
CAB
325
DELISTED
Cabela's Inc
CAB
| $1.85M | 0.01% |
27,783
+8,270
| +42% | +$514K |
|
Similar funds
Bessemer Group's Q4 2013 Portfolio in Review
As of Q4 2013, Bessemer Group held 1,448 positions worth $14B, up 13% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bessemer Group's Q4 2013 filing shows 199 new, 366 increased, 275 reduced and 98 closed positions. Its largest new stake was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M. The largest sale was Teva Pharmaceuticals, an estimated $98.9M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Bessemer Group's largest Q4 2013 buy was iPath Pure Beta Broad Commodity ETN: 1,927,069 shares worth $76.1M.
- Bessemer Group added most to Viatris in Q4 2013, an estimated $154M increase.
- Bessemer Group's biggest Q4 2013 reduction was Teva Pharmaceuticals, cutting an estimated $98.9M.
- Bessemer Group fully exited Rayonier in Q4 2013, selling an estimated $33.4M.
- Bessemer Group's ten largest holdings make up 16% of its $14B portfolio in Q4 2013.
- Bessemer Group opened 199 new positions and closed 98 in Q4 2013.
- Bessemer Group's portfolio value rose 13% quarter-over-quarter to $14B.
Based on Bessemer Group's 13F filing for Q4 2013, filed 18 Feb 2014.